HOME >> BIOLOGY >> NEWS
UT Southwestern researchers learn importance of insulin family signaling in male sex determination

DALLAS Nov. 20, 2003 Researchers at UT Southwestern Medical Center at Dallas have shown that insulin family signaling is important for male sex determination, a discovery that furthers the understanding of testes formation and eventually could lead to treatments for reproductive disorders.

Their findings appear in the current issue of Nature and are available online.

"We are excited by this research for two reasons," said Dr. Luis Parada, senior author of the Nature study and director of the Center for Developmental Biology. "First, the intracellular signaling pathways that mediate male sexual differentiation have remained elusive despite the fact that the controlling gene that unleashes the process was identified almost 15 years ago. Second, our experience with studying receptors and signaling in development provides us with the skills and tools to tackle this problem, which has tremendous implications in newborn disorders."

UT Southwestern researchers now want to determine if the insulin-signaling pathway is active in human gonad formation. It has been found only in mice, but there is a strong likelihood it exists in humans.

"If the insulin-signaling pathway turns out to be important in humans, we'll be able to activate the pathway because we know what proteins to manipulate," said Dr. Sunita Verma-Kurvari, postdoctoral researcher in the Center for Developmental Biology and co-first author of the study. "We someday may even be able to correct reproductive disorders by activating them with therapeutics."

In mice, the male sex-determining process begins in a region of the Y chromosome called Sry, Dr. Verma-Kurvari said. Sry triggers differentiation of the Sertoli cells, which act as organizing centers and direct formation of the testes.

Without Sry, XX or XY gonads failed to develop testes (male reproductive organs producing sperm and male sex hormones), and male to female sex reversal ensued in the mice
'"/>

Contact: Scott Maier
scott.maier@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
19-Nov-2003


Page: 1 2 3

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. RSV can increase the risk of asthma, UT Southwestern researchers find
4. Searle Scholars program awards $240,000 to UT Southwestern researcher
5. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
8. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
9. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
10. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
11. UT Southwestern research halts narcolepsy symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access ... (CEG) to market and sell its complete line of biometric readers and access ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for ...
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, ... their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at ... place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... background and medical screening, announces the launch of a testing service aimed ... safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... , ... Greffex, a leading genetic engineering company, with the ... vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to produce ... successful gene therapy delivery vehicle (vector) with broad applications for delivering treatments including ...
(Date:6/11/2020)... ... 2020 , ... Reducing carbon emissions has been and will continue to be ... market dips, ways to reduce CO2 is something we can’t avoid. , To ... biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, these ...
Breaking Biology Technology:
Cached News: